Home » Archive

Diagnostics

Diagnostics, News, Syndication, Xconomy »

Epic Sciences Compiling Data on Ultra-Sensitive Cancer Diagnostic

Posted by sandiegobiotech January 29th, 2014 .
No Comments

San Diego’s Epic Sciences said today it has signed an agreement with LabCorp (NYSE: LH) to help speed up European clinical trials that are using Epic’s technology to identify tumor cells in the…

[[Click headline to continue reading.]]

More...

Diagnostics, News, Syndication, Xconomy »

Using Cutting-Edge Science and Technology Against an Age-Old Disease

Posted by sandiegobiotech January 24th, 2014 .
No Comments

When I started working on the research and science of leprosy more than a decade ago, people thought this chronic infectious disease would eliminate itself and burn out over time. We didn’t have time…

[[Click headline to continue reading.]]

More...

Diagnostics, News, Syndication, Xconomy »

10 Tips for Maximizing the JP Morgan Healthcare Experience

Posted by sandiegobiotech December 23rd, 2013 .
No Comments

San Francisco, we’re coming. Of course, you are ready for the biotech onslaught. The cab drivers, hotel people, cops, security dudes, restaurant and bar staff—you all know the drill come…

[[Click headline to continue reading.]]

More...

Diagnostics, News, Syndication, Xconomy »

3 Life Sciences Companies That Are Built to Last

Posted by sandiegobiotech December 2nd, 2013 .
No Comments

Lots of biotech companies today say they want to be great for a long, long time. But which of today’s companies are actually doing it? Which ones are truly visionary, and built to last? These…

[[Click headline to continue reading.]]

More...

Diagnostics, News, Syndication, Xconomy »

The Biotech Startup Class of 2013: Don’t Worry, It’s a Short List

Posted by sandiegobiotech November 18th, 2013 .
No Comments

[Updated: 5 pm PT 12/04/13] We’ve heard a lot this year about the IPO boom for biotech companies. Even after a few high-profile blowups (Ariad, Sarepta), the public biotech stock indexes are still…

[[Click headline to continue reading.]]

More...

Diagnostics, News, Syndication, Xconomy »

San Diego Life Sciences Roundup: IPOs, Illumina, KFx Medical, & More

Posted by sandiegobiotech October 17th, 2013 .
No Comments

The surge in U.S. initial public offerings has continued. According to the IPO experts at Renaissance Capital, there have been 44 healthcare IPOs across the country so far this year—the most in…

[[Click headline to continue reading.]]

More...

Diagnostics, News, Syndication, Xconomy »

BioNano Genomics Raises $10M from Venture Investors

Posted by sandiegobiotech October 2nd, 2013 .
No Comments

San Diego’s BioNano Genomics said today it has raised $10 million in venture financing to continue commercializing its long-strand gene sequencing technology in the United States, Europe, and Asia….

[[Click headline to continue reading.]]

More...

Diagnostics, News, Syndication, Xconomy »

San Diego Life Sciences Roundup: Ex-CEO Shoots Two, OncoSec, & More

Posted by sandiegobiotech September 19th, 2013 .
No Comments

[Updated 9/21/13 8 pm. See below.] It was a quiet week for life sciences news in San Diego, except for a shooting spree in La Jolla that wounded two people, including a prominent UC San Diego cancer…

[[Click headline to continue reading.]]

More...

Diagnostics, News, Syndication, Xconomy »

Don’t Be Naïve: 7 Things to Know Before Taking a Biotech Startup Job

Posted by sandiegobiotech September 16th, 2013 .
No Comments

You’ve spent years working hard to hone your skills in science, medicine, or business. You’ve accomplished things, and you have the talent and desire to do more. You may be bored, or stuck at a…

[[Click headline to continue reading.]]

More...

Diagnostics, News, Syndication, Xconomy »

Applied Proteomics Snags $28M to Look for Disease Markers in Blood

Posted by sandiegobiotech August 21st, 2013 .
No Comments

San Diego’s Applied Proteomics, founded in 2007 to automate the process of accurately measuring all the protein fragments in a drop of blood, has raised $28 million in a Series C round of financing….

[[Click headline to continue reading.]]

More...